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CHAPTER 1 
INTRODUCTION 
 Ionizing Radiation 
 Ionizing radiation results in the removal of electrons from the orbit of an atom or 
molecule, thereby forming unstable ions. The resulting ionized molecules can cause 
direct damage to DNA leading to single or double strand breaks. Single strand breaks 
are comparatively easy to repair since the undamaged DNA strand serves as a 
template. Double strand breaks cause DNA rearrangements which lead to more severe 
biological consequences resulting in cell cycle arrest, senescence, or cell death.  
 
Radiation types and properties  
To understand the biological effects of radiation exposure, a basic understanding 
of radiation physics is needed. Ionizing radiation can consist of atomic or subatomic 
particles such as alpha and beta particles, and protons and neutrons, which all have 
mass, or photons (X-rays and γ-rays) that have properties of high energy 
electromagnetic waves. γ-rays are characterized as low linear energy transfer (low-LET) 
radiation (Hill 2004). LET refers to the amount of energy transferred along the linear 
path of radiation in matter such as tissue. The energy transferred by X-rays and γ-rays 
results in less ionization along their paths and less homogeneous ionization within the 
cells than particles such as protons, neutrons, and α-particles which deposit more 
energy per distance travelled, and are therefore considered to be high-LET radiation. 
Radiation dose is measured in Gray (Gy), which is defined as the energy absorbed per 
unit mass. One Gray of ionizing radiation is equivalent to 1 joule of energy absorbed per 
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kilogram of matter (J/kg). One way to assess the risks of cancer arising from exposure 
to a particular radiation source is to measure the biological effects per unit of dose 
absorbed by the matter, which is often expressed in Sieverts (Sv). The overall aim of 
the current study was to understand the biological consequences of exposures to low 
doses of γ-rays. 
 
Damaging effects of radiation 
Much of our knowledge of the human health consequences of radiation exposure 
is due to studies that focused on the effects of the atomic bombs detonated over 
Hiroshima and Nagasaki in 1945 (Cronkite et al. 1955; Bond and Cronkite 1957; Little 
2009; Douple et al. 2011). The biological consequences of exposure to radiation have 
also been well documented in studies performed on cleanup workers from the 1986 
nuclear power plant accident at Chernobyl, Ukraine (Moore et al. 1997; Moore and 
Tucker 1999; Jones et al. 2002). In addition to war and accident survivors, 
epidemiological studies on radiation workers (Cardis et al. 1995; Tucker et al. 1997; 
Sont et al. 2001; Cardis et al. 2007; Leung et al. 2011; Ostroumova et al. 2014) and 
radiotherapy patients (Kleinerman et al. 2005; Curtis RE FD 2006; Leung et al. 2011) 
have provided much information on the actual biological damage post exposure. The 
detrimental effects of the consequences of the atomic bombings in Japan and the 
Chernobyl accident are due to high-energy electromagnetic waves that interact with the 
cells and displace electrons, causing damage to biomolecules and thus inducing 
oxidative stress. At high acute doses (> 1 Gy), both direct and indirect damage to cells 
is severe and will affect most of the cellular processes including DNA damage repair. 
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However, at low doses (< 1 Gy), repair of direct and indirect DNA damage is initiated 
but may be inefficient in restoration of the damage, thereby resulting in point mutations 
and DNA rearrangements.  
Relatively high doses in humans lead to Acute Radiation Syndrome (ARS). There 
are three distinct classical syndromes of ARS. The first is bone marrow (or 
hematopoietic) syndrome, which results in destruction of bone marrow leading to a 
weakened immune system and increased hemorrhage. The hematopoietic syndrome is 
observed even with acute radiation exposures as low as 0.7 Gy and is very severe at 10 
Gy. The second is gastrointestinal (GI) syndrome, which causes damage to the GI tract 
leading to vomiting, nausea, severe dehydration, and death within a few weeks. GI 
syndrome is due to radiation exposures that are approximately 6 Gy. Finally, the 
cardiovascular (CV) / central nervous system (CNS) syndrome is caused by extremely 
high dose exposures of 20 - 50 Gy. An exposure to such severe acute doses results in 
the collapse of the circulatory system and increased pressure in the brain due to 
accumulation of fluids. The CV / CNS syndrome results in death in a few hours or days 
due to severity of its symptoms (Reeves 1999). An important consideration is that 
different doses cause different specific features of ARS in different organs, reflecting 
their radiosensitivities.  
 
Human exposures to radiation 
 As stated earlier, human exposure to high doses of radiation have occurred 
mostly due to war or accidents, as evidenced in the atomic bomb explosions in Japan 
and the Chernobyl nuclear power plant accident in Ukraine. The unfortunate natural 
disaster leading to the meltdown of nuclear material at the Fukushima Daiichi nuclear 
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power plant in Japan in 2011 is currently causing tremendous concern because the 
radiation levels have been reported to be very high in parts of the surrounding area. 
Some kinds of fruits and vegetables, milk and water in regions in and near Daiichi are 
reported to have radioactivity much above the background radiation. 
 We are constantly exposed to radiation by a variety of natural and artificial 
sources. Natural background radiation sources include radioactive elements found in 
the water and food, radon gas released from the earth’s crust, and cosmic rays. 
According to the United Nations Scientific Committee on the Effects of Atomic Radiation 
(UNSCEAR), the global average radiation dose from natural background radiation is 
approximately 2.4 mSv per year (UNSCEAR 2000; Mettler et al. 2007). The annual 
dose from natural background radiation varies depending upon location, with some 
areas emitting significantly higher doses of radiation, for example, Ramsar in Iran, 
Kerala in India, Guarapari in Brazil, northern Flinders Range in Australia, and Yangjiang 
in China. Within the United States, the National Council on Radiation Protection (NCRP) 
monitors the amount of radiation exposure to the general population. The NCRP has 
reported that the current average global effective radiation dose is approximately 3.0 
mSv per year, however their recent reports indicate that these values have almost 
doubled and are now considered to be about 5.7 mSv per year, which includes all 
radiation sources (NCRP 2009). This difference between the radiation exposures is not 
due to changes in the natural sources but due to increased medical radiological 
procedures, as shown in Table 1.1. These procedures were for most part considered 
“safe” for many years, however many studies have demonstrated chromosome damage 
at doses below 0.5 Gy exposures (Tucker et al. 1998; Bhatti et al. 2010).   
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Table 1.1. Average effective annual radiation dose from current standard medical 
procedures* 
 
*Modified from www.radiologyinfo.org/en/safety/index.cfm?pg=sfty_xray; accessed on 
08/20/2014.  
  
Medical Procedure 
Approximate effective 
annual radiation dose 
(mSv) 
Radiography (X-ray) - GI Tract 6.0 – 8.0 
Radiography (X-ray) – Spine 1.5 
Radiography (X-ray) - Extremity 0.001 
Radiography (X-ray) - Chest 0.1 
Radiography (X-ray) - Dental 0.005 
Computed Tomography (CT) -Abdomen and Pelvis 15 - 30 
Computed Tomography (CT) – Colonography 10 
Computed Tomography (CT) - Head 2 – 4 
Computed Tomography (CT) - Spine 6 
Computed Tomography (CT) - Chest 1.5 - 7 
Mammography 0.4 
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 The American population’s exposure to increasing amounts of radiation for 
medical imaging has raised concerns over the increased cancer risk from diagnostic 
radiology, especially that of Computed Tomography (CT) scanning (Brenner and Hall 
2007). Brenner and Hall proposed that this increase in the CT scanning alone raises 
cancer risk by 1.5 – 2%. Bhatti et al. (Bhatti et al. 2010) demonstrated significant 
increases in chromosome translocations, even in healthy individuals, post exposure to 
X-rays performed annually. The Bhatti et al. and Brenner et al. studies emphasize that 
long term health risks associated with low dose radiation exposures are currently under-
estimated and thus need to be further investigated. 
 
Biological effects at low dose exposures 
 A program focusing on the biological effects of low dose exposures by the U.S. 
Department of Energy identifies low dose radiation as exposures ≤ 20 cGy 
(http://lowdose.energy.gov/default.aspx), which are considerably higher than the natural 
background radiation levels. However, evaluating long-term effects of exposures at low 
doses and achieving accurate risk analyses is difficult since the ultimate concern 
stemming from radiation exposure is cancer, which may be caused due to additional 
factors such as age and life style choices (Fuglede et al. 2011; Srivastava et al. 2011). 
Therefore, the risks of exposure to low doses are currently estimated based on data 
obtained at high doses. With continued exposure to radiation through medical imaging 
systems, a larger population in general is exposed to doses that are above natural 
background radiation (Table 1.1). Therefore, a clear understanding of the risks involved 
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at low doses is needed for a meaningful risk-reward analysis of such radiation 
exposures. 
 The current method for low dose risk assessment is linear-no-threshold (LNT) 
extrapolation from the high dose data, which is an approach that has been used for the 
past 50 years (ICRP 1991). According to the LNT hypothesis, risk is directly proportional 
to radiation dose (Rothkamm and Lobrich 2003). The LNT models further propose the 
“dose additivity” concept, which suggests that radiation-induced DNA damage 
accumulates over time and increases the risk of carcinogenesis (Mitchel 2007). 
However, an increasing amount of evidence questions the validity of the LNT models. 
 Two alternatives to the LNT models are the linear threshold models and the 
hormesis and adaptive response models. The linear threshold models suggest that 
below a certain threshold there is no detectable risk (Tanooka 2001; Pierquin et al. 
2007). According to the hormesis and adaptive response models, low levels of radiation 
exposure prior to a high dose can actually reduce the risks of radiation-induced cellular 
damage (Yonezawa et al. 1990; Day et al. 2007; Sethu et al. 2008; Jeggo 2009) and 
are therefore in direct opposition to the “dose additivity” tenant of the LNT models. In 
contrast, the non-targeted radiation-induced bystander effect amplifies the radiation 
response in unirradiated cells leading to an increased risk at low doses that is 
unpredicted by the LNT models (Hamada et al. 2006; Little 2006; Prise 2006). Thus, 
accurate assessments of risks from low dose radiations are essential for the 
development of adequate radiation exposure limits imposed by governments. 
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Cellular responses to low-dose exposures 
 Radiation exposure leads to breaks in the double helix and can potentially cause 
cancer. At the same time, radiation also provides powerful tools for treating cancers. 
The dual role of radiation, in both causing DNA damage as well as its therapeutic 
benefits, is due to the intricate molecular pathways triggered. Cellular responses to DNA 
damage depend on the cell and tissue type (Helleday et al. 2008; Kinner et al. 2008) as 
well as the nature and magnitude of the damage (Gudkov and Komarova 2007).  
 Improvements in cell survival assays have also been important for studying low 
dose phenomena such as hyper-radiosensitivity (HRS) (Marples and Collis 2008). HRS 
can be described as an increased sensitivity of cells in G2 phase to low dose radiation 
and has been observed in a wide range of cell types and tissues (Joiner et al. 1993; 
Marples and Joiner 1993; Wouters et al. 1996; Ryan et al. 2008). At doses in the range 
of 0 – 30 cGy, mammalian cell survival assays display HRS as a steep slope of the 
dose response curve that is a result of increased cell death at these doses. For slightly 
higher doses, in the range 30 – 60 cGy, an induced radiation resistance (IRR) effect is 
observed wherein cells display increased survival (Figure 1.1). 
 The mechanisms underlying HRS / IRR are not completely understood. At low 
doses the early G2/M checkpoint is not completely activated, suggesting the 
involvement of ataxia telangiectasia mutated (ATM) kinase (Bakkenist and Kastan 2003; 
Buscemi et al. 2004; Lobrich and Jeggo 2005; Wykes et al. 2006; Krueger et al. 2010; 
Martin et al. 2013). In the absence of the G2 / M checkpoint, cells with damaged DNA 
enter mitosis leading to cell death. Some studies have also shown that the HRS effect 
translates to increased apoptosis for low doses (Enns et al. 2004; Krueger et al. 2007b). 
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Interestingly, the HRS / IRR-related effect is also observed in various tissues (Joiner 
and Johns 1988; Joiner et al. 2001b). However, a better explanation of the HRS / IRR 
effect is required to help estimate actual damage caused at low doses. This will help 
obtain better analyses of the risks involved for improved treatment options.  
 Chapter 2 of this dissertation describes the work performed to evaluate radiation-
induced G2-specific HRS effects at 0 – 20 cGy in four normal human lymphoblastoid 
cell lines using cytogenetics. Based on the clonogenic cell survival data from other 
studies (Marples and Collis 2008; Martin et al. 2013), we hypothesized that the slope of 
the response curve at very low doses (line “C” in Figure 1.2) will be greater than the 
extrapolated curve (line “B” in Figure 1.2). We provide cytogenetic evidence of HRS in 
all four cell lines tested in this study (Chapter 2). Prior to conducting this work, there 
was the possibility that the slope of the response would be lower than the extrapolated 
curve (line “D” in Figure 1.2). The results shown here strongly support the expectation of 
the slope being greater than the extrapolated data, and argue strongly against the 
alternate hypothesis of the slope being less than that derived by extrapolation. 
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Figure 1.1 Clonogenic cell survival curve below 100 cGy. At doses from 0 
– 30 cGy, mammalian cells demonstrate hyper-radiosensitivity (HRS), and 
show induced radiation resistance (IRR) between 30 and 60 cGy. The 
current method of risk analyses at low dose exposures is to extrapolate the 
data obtained from the high doses (above 1 Gy). However, due to the 
HRS/IRR effect, extrapolation does not consider the changes in the typical 
cell survival curves for radiation-induced sensitivity (αs) or resistance (αr) 
as indicated here. This image was obtained from Marples et al., (Marples 
and Collis 2008). 
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Figure 1.2. Possible response curves at low doses. Cytogenetic damage 
increases with amount of radiation based on high dose exposures (A). At low 
doses the damage has sometimes been estimated by extrapolating the response 
from the high doses (B); this is the approach used by Linear No Threshold 
models. Outcome C is strongly supported by the cytogenetic evidence of the 
HRS, which is discussed in Chapter 2. The alternate outcome D is currently not 
supported by literature. 
 
  
	  	  
12 
Effect of oxygen (O2) levels on radiation responses 
 Most in vitro radiobiological experiments are conducted under ambient 
atmospheric O2 levels (~21%), a value that exceeds the in vivo physiological O2 levels 
(~5%) by about four-fold in most normal tissues. O2 levels may even be lower than 5% 
in some solid tumor microenvironments. Compared to cells grown at physiological O2 
levels, culturing cells in ambient O2 results in increased intracellular amounts of hydroxyl 
ions that result in DNA strand breaks (Henderson and Miller 1986; Boregowda et al. 
2012; Koukourakis 2012). With hypoxic conditions there are fewer DNA strand breaks 
and these appear to be repaired efficiently due to activation of ATM and ATR mediated 
DNA repair pathways (Cam et al. 2010; Mongiardi et al. 2011; Stagni et al. 2014). The 
biological effects of radiation are highly influenced by O2 levels, with hypoxia and anoxia 
making cells two to three times more resistant to radiation (Palcic et al. 1982; Marples et 
al. 1994b; Hockel and Vaupel 2001; Ma et al. 2013). Tumor hypoxia, especially before 
radiotherapy, is known to be associated with poor clinical prognosis (Semenza 2012). 
Hypoxia is related to tumor development, metastatic capacity and malignant 
progression, and results in resistance to therapy at doses above 1 Gy (Brown et al. 
2010; Hanahan and Weinberg 2011; Song et al. 2011). 
 Many solid tumors often have areas with inadequate circulation due to 
structurally disorganized blood vessels and because of cells that replicate faster than 
the developing tumor capillary network (Hockel and Vaupel 2001; Brown 2002; 
Rockwell et al. 2009). The fraction of solid tumors that are hypoxic (with O2 levels below 
physiological conditions), and the degree of hypoxia in tumors, vary considerably 
(Moulder and Rockwell 1987; Teicher et al. 1995). Tumors display two types of hypoxia, 
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1) chronic hypoxia due to limited diffusion of oxygen in tissues as a result of impaired 
tissue vasculature and 2) acute hypoxia, due to poor blood perfusion in the existing 
blood vessels (Vaupel and Harrison 2004). Both chronic and acute tumor hypoxia lead 
to induced radioresistance (Garcia-Barros et al. 2003). Radiation resistance is partly 
due to increased DNA repair and decreased apoptosis due to activation of hypoxia 
inducible factors (Robertson et al. 2009; Aypar et al. 2011). Thus, poor tumor 
oxygenation directly results in failure of the radiation treatment (Hockel et al. 1993; 
Parker et al. 2004; Rockwell et al. 2009). Therefore, true cellular radiation responses 
may be masked or distorted by an unnaturally high level of oxidative lesions imposed by 
atmospheric O2. In Chapter 3 we explored the consequences of low O2 levels on 
irradiated normal human lymphoblastoid cells. In addition to the low O2 levels, we also 
evaluated the consequences of post-radiation re-oxygenation to ambient air and post-
irradiation hypo-oxygenation. Our results call into question the soundness of the in vitro 
experimental methods used for understanding radiation-induced cellular damage in 
human cells cultured in ambient air.  
 
DNA repair processes 
 DNA damage detection and repair is required for normal cell development and 
survival. Radiation-induced double-strand breaks cause DNA rearrangements ultimately 
affecting cell survival (Noda et al. 2012). Thus, radiosensitivity of the cells depends on 
their capacity to repair the damaged DNA and varies among cells. Increased 
radiosensitivity is evident in cancer patients with mutations in repair enzymes such as 
ATM, resulting in a high fraction of cell killing (Thompson 2012). Thus, the response to 
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damage is crucial for the cells to divide and proliferate, or die. In addition to the initiation 
of the repair processes, the “quality” of repair is also important for the DNA to be 
functional. For example, the detection of DNA double strand breaks by ATM can initiate 
repair mechanisms which in turn leads to the activation of the tumor suppressor gene 
p53 (Canman and Lim 1998). The p53 protein plays an important role in controlling cell 
cycle arrest and also acts as a pro-apoptotic enzyme that by stimulating caspase 
activity leads to cell death by apoptosis (Thompson 2012; Han et al. 2014).  
 The repair of DNA double strand breaks is either accomplished via homologous 
recombination repair (HRR) or non-homologous end joining (NHEJ). HRR utilizes the 
corresponding undamaged DNA on the sister chromatid as a template for repairing the 
damage, resulting in perfect repair (Thompson 2012; Symington 2014). In the NHEJ 
repair the DNA strands are ligated, ignoring the missing base pairs in the process 
(Mahaney et al. 2009), thus causing the loss of some genetic information ultimately 
resulting in translocations and telomere fusions (Thompson 2012). DNA repair that is 
not functional or adequate can lead to mitotic catastrophe that in turn results in cell 
death. 
Progression through the cell cycle is also important when considering 
radiosensitivity. Cells exhibit differential radiosensitivity in different cell cycle phases, 
being sensitive in G2-M and resistant in late S phase (Terasima and Tolmach 1963). 
One possible explanation for this radiation resistance in S phase is that the sister 
chromatid is opened and readily accessible for homologous repair of DNA double strand 
break. The potential long-term impact of radiosensitivity based on cell-cycle phases 
post-radiation is explored in Chapters 2 and 3. 
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Cytogenetic analyses of chromosome damage 
 Ionizing radiation is known to cause damage to DNA. Classical cytogenetic 
analyses of chromosome aberrations are considered to be the gold standard for 
biological dosimetry. The cytokinesis-blocked micronucleus (CBMN) assay is a 
commonly used, fast, simple, and sensitive cytogenetic method which can efficiently 
identify three different endpoints simultaneously, namely micronuclei (MN), 
nucleoplasmic bridges, and nuclear buds.  
 Radiation-induced MN are derived from acentric chromosomes, chromatid 
fragments, or lagging whole chromosomes that did not attach to the spindle fibers 
during nuclear division and hence were excluded from the daughter nuclei. These 
fragments and lagging chromosomes are enclosed in a nuclear membrane forming one 
or more MN (Figure 1.3, A and B) (Eastmond and Tucker 1989b; Albertini et al. 2000; 
Fenech et al. 2011). Nucleoplasmic bridges are formed when the centromeres of 
dicentric chromosomes become attached to spindle fibers from opposite poles during 
nuclear division. The nuclear membrane develops around the daughter nuclei as well as 
the dicentric chromosome(s) resulting in one or more nucleoplasmic bridges (Figure 1.3, 
C and D). The mechanisms of formation of nucleoplasmic buds are not well understood. 
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Figure 1.3. Images of Giemsa stained binucleated cells with micronuclei (A 
and B) and nucleoplasmic bridges (C and D).  
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 A commonly used cytokinesis blocking agent is Cytochalasin B, which inhibits 
polymerization of actin filaments, thus preventing the formation of the microfilament ring 
which constricts the cytoplasm during the cell division leading to formation of 
binucleated cells (Fenech 2000). The MN and bridges expressed in the cytokinesis-
blocked binucleated cells are easily scored to enumerate chromosome damage 
(Fenech 2000; Fenech et al. 2003). We used the CBMN assay and specifically 
evaluated the frequencies of MN and bridges as cytogenetic endpoints for the studies 
described in Chapters 2 and 3. The data for nuclear buds did not yield any meaningful 
results and for this reason were excluded from further analyses in both studies.  
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CHAPTER 2 
Cytogenetic characterization of low-dose hyper-radiosensitivity in Cobalt-60 
irradiated human lymphoblastoid cells 
 
INTRODUCTION 
 Radiation-induced damage and the associated cancer risks are well known for 
high doses, however substantial uncertainty still exists about the health risks associated 
with low-dose exposures (Pierce and Preston 2000; Brenner et al. 2003; Scott 2008; 
Morgan and Bair 2013). Human exposure to radiation has increased considerably over 
the past few decades due to more frequent use of CT imaging and radiological 
procedures. Currently the estimates of the biological damage at low-dose exposures are 
based on linear extrapolation of the available high dose (> 100 cGy) data. However at 
low-dose exposures (≤ 100 cGy), radiation responses have been observed to deviate 
from linearity (Zaichkina et al. 2004; Scott 2008). 
 Clonogenic cell-survival assays involving mammalian cells exposed to X-rays 
have identified hyper-radiation sensitivity (HRS) effects, where increased cell death is 
observed at low doses (≤ 50 cGy) accompanied by induced radiation resistance (IRR) at 
slightly higher doses (≥ 60 cGy) (Joiner et al. 1996; Wouters and Skarsgard 1997; 
Joiner et al. 2001a; Marples and Collis 2008; Martin et al. 2013). HRS has been 
investigated for increased tumor cell killing as a way to treat cancer and might also 
protect normal tissues against carcinogenesis following low-dose radiation exposures 
(Lambin et al. 1994). The potential clinical significance of HRS is not well understood 
(Martin et al. 2013), and the mechanisms underlying the HRS/IRR effect are unclear. 
However, evidence suggests that faithful DNA repair and effective cell cycle regulation 
may be diminished at very low doses (Marples et al. 2004; Krueger et al. 2010). 
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Radiation-induced DNA damage triggers activation of checkpoints in the G1/S, S, and 
G2 phases of the cell cycle which allow time for repair of damaged DNA before cell 
cycle progression recommences (Wilson 2004). The HRS/IRR effect is predominantly 
observed in G2 (Joiner et al. 1996; Short et al. 2003; Marples 2004), suggesting that the 
rapidly occurring G2 cell cycle checkpoint regulates the mechanisms of the HRS/IRR 
effect. During G2, radiation-induced DNA damage is verified by two distinct cell cycle 
checkpoints, one which arrests cells that have incurred damage in G1 or S (Sinclair 
1968) and the other (called the rapid G2/M check point) is triggered when cells in G2 
are exposed to radiation (Xu et al. 2002). The rapid G2/M checkpoint depends on the 
ataxia telangiectasia mutated (ATM) protein and is known to activate at ≥ 40 cGy (Xu et 
al. 2002; Krempler et al. 2007). Thus, cells exposed to doses below 40 cGy in G2 may 
fail to recognize the damage and enter mitosis before adequate DNA repair occurs, 
thereby exhibiting an HRS effect (Short et al. 2003; Wykes et al. 2006; Krueger et al. 
2007a; Marples and Collis 2008). 
 Here we investigated cells exposed to Cobalt-60 gamma rays in G2 by 
comparing the slopes of the dose-responses for micronuclei and nucleoplasmic bridges 
in the low-dose region (< 50 cGy) to responses at higher doses (> 60 cGy). The data for 
four independent normal human lymphoblastoid cell lines indicate that cells irradiated in 
G2 with doses ≤ 20 cGy show increased cytogenetic damage per unit dose compared to 
doses of 60 cGy and higher, and thus exhibit an HRS effect. We also evaluated the 
shape of the dose-responses of the G2 irradiated cells and compared them to the 
responses of the G1 irradiated cells for all four cell lines. The data indicate that at low 
doses, the responses of the G2 irradiated cells deviate from linearity, thus suggesting 
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that back-extrapolation of the high dose responses may lead to underestimates of the 
actual damage. These findings suggest that the increased cell killing in the HRS region 
of G2 irradiated cells seen by others reflects the cytogenetic damage observed here, 
emphasizing the importance for better understanding of the HRS effect and the 
influence it can have on radiation risk assessments following low-dose exposures. 
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MATERIALS AND METHODS 
Cell lines and cell culture 
Four normal human lymphoblastoid cell lines GM15036, GM15510, GM15268, 
and GM15526 obtained from the Coriell Cell Repository were used in this study. The 
cells were cultured based on a standard protocol provided by Coriell. Briefly, the cells 
were grown in T-25 flasks (ISC BioExpress, Kaysville, UT) containing 10 ml of 
RPMI1640 medium (GIBCO, Grand Island, NY and Hyclone, Logan, UT) supplemented 
with 15% Fetal Bovine Serum (FBS, Atlanta Biologicals, Lawrenceville, GA), 2 mM L-
glutamine (GIBCO, Grand Island, NY), penicillin-streptomycin (100 units/ml penicillin G 
Sodium, 100 µg/ml streptomycin sulfate in 0.85% saline) (GIBCO, Grand Island, NY) 
and fungizone (amphotericin B, 2.5 µg/ml, 0.2 µm filtered) (Hyclone, Logan, UT) with 
loosened caps. Cell cultures were maintained at 37°C and 5% CO2 in a fully humidified 
incubator, and passaged every three to four days when their density reached 106 
cells/ml. 
 
Irradiation 
Twenty-four hours after seeding the flasks, the cells were acutely exposed to 
Cobalt-60 γ-radiation at a dose rate of approximately 28 cGy/min at the Gershenson 
Oncology Center, Wayne State University, Detroit, MI. Each cell line was individually 
exposed to 0, 5, 10, 20, 40, 60, 80, 100, 200, 300, or 400 cGy. Each experiment was 
independently replicated once for each cell line.  
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Cell cycle kinetics and harvest 
To measure cell cycle kinetics, flow cytometric analyses were performed on 
GM15036 and GM15510 cells by the Flow Cytometry Core facility, Wayne State 
University. The length of the G2 phase in GM15510 and GM15036 cells was 
determined to be approximately 1.5 and 2 hours, respectively, and the cell cycle 
durations were approximately 20 and 22 hours for GM15510 cells and GM15036 cells, 
respectively. The harvest times were based on these results to ensure that most 
binucleated cells scored were in G2 to observe a hyper-radiation sensitivity / induced 
radiation resistance (HRS/IRR) effect (Joiner et al. 1993) or in G1 for the comparison 
experiments. 
 The growth rates of GM15268 and GM15526 cells were determined by a cell 
viability assay, using 0.4% Trypan blue (in phosphate buffered saline; Fisher Scientific, 
Pittsburg, PA). Briefly, cells were seeded at an initial concentration of 3x105 cells per ml 
and cultured as described above. An aliquot of cells was taken every 24 hours and the 
number of live cells per ml was determined using a standard hemocytometer (Fisher 
Scientific, Pittsburg, PA). The growth kinetics of both the GM15268 and GM15526 cells 
were comparable to those of GM15510 and GM15036, thus the harvest times were 
established as 2 and 22 hours after radiation to probe the G2 and G1 phases, 
respectively.  
 
Cytokinesis-blocked micronucleus (CBMN) assay 
 Cytogenetic damage was measured using the CBMN assay. Immediately 
following irradiation, 6 µg/ml of Cytochalasin B (final concentration; Sigma Aldrich, St. 
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Louis, MO) was added to the flasks, which were immediately returned to the incubator. 
At harvest, the cells were resuspended and spun onto ethanol-cleaned microscope 
slides using a cytocentrifuge (Statspin, Westwood, MA) at 1300 rpm for 4 minutes. The 
slides were air dried, fixed in 100% methanol (Fisher Scientific, Pittsburgh, PA) for 15 
minutes, stained with 10% Giemsa (Sigma Aldrich, St. Louis, MO) dissolved in water for 
15 minutes, then briefly rinsed in water and air-dried.  
 
Data collection 
 Slide readers were extensively trained prior to data collection. An equal number 
of readers scored equivalent numbers of cells for each treatment condition for all four 
cell lines, both replicates and both harvest times (G1 and G2). To ensure that adequate 
numbers of binucleated cells were available after irradiation, the nuclear division index 
(NDI) was calculated as described (Eastmond and Tucker 1989a). For each treatment 
condition, 200 cells were counted to determine the frequency of cells with 1, 2, 3 or 4 
nuclei using the formula 
NDI = (M1 + 2M2 + 3M3 + 4M4) / N 
where M1 to M4 represent the number of cells with 1 to 4 nuclei and N is the total 
number of cells scored.  
 
Cell scoring criteria 
 The slides were evaluated for micronuclei, nucleoplasmic bridges and buds 
simultaneously, based on established criteria (Fenech 2000; Cheong et al. 2013) using 
Nikon Eclipse E200 light microscopes at 1000X magnification. As shown in Figure 2.1, 
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all cells scored were binucleated where the two main nuclei were separate from each 
other and the cell membranes were intact. The micronuclei were required to be one-
third the size of the main nuclei or smaller, smooth edged, round or oval, stained similar 
to the main nuclei, and had to be located within the cytoplasm. The nucleoplasmic 
bridges were required to be colored similar to the nuclei and to be connected to both 
nuclei. Although buds were scored, they were relatively infrequent and did not yield 
meaningful results, so these data are not reported here. All slides were coded prior to 
scoring to avoid observer bias. At least 1000 binucleated cells were scored for each 
treatment condition.  
 
Statistical analyses 
 The dependence of cytogenetic damage on dose was evaluated to 
characterize the HRS/IRR effect by comparing the responses in G1 and G2, and to 
evaluate the shape of the responses of G2-irradiated cells with those of the G1-
irradiated cells. The slopes of the responses were evaluated by performing univariate 
linear regression analyses independently on each cell line and replicate, and by 
multivariate linear regression analyses on the combined data for both replicates and all 
four cell lines using JMP software, version 6.0, SAS Institute Inc. For univariate 
analyses the frequencies of MN and bridges per 1000 binucleated cells were 
independently regressed against dose. For multivariate analyses the frequencies of MN 
and bridges per 1000 binucleated cells were evaluated in linear regression models 
using dose, cell line, cell cycle phase, experimental replicate, and an interaction term for  
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Figure 2.1. Examples of MN and bridges in binucleated cells. A: cell with 
one MN. B: cell with two MN and a bridge. C: cell with a broad bridge. D 
cell with thinner bridge.  
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cell line and replicate. The individual slopes obtained at the low- and the high-dose 
regions for the G2 and G1 responses were compared by calculating their ratios. 
Radiation sensitivity per unit dose for MN and bridges was measured by 
calculating the slope of the line obtained between the frequency at the 0-cGy control 
and the frequency at each individual radiation dose. These individual slope values were 
then plotted against dose. 
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RESULTS 
 Cytogenetic damage for MN and bridges was assessed in normal human 
lymphoblastoid cells irradiated with 0 – 400 cGy in G1 and G2. The results demonstrate 
the existence of a non-linear response in G2 for doses <100 cGy, and a clear evidence 
of the HRS effect < 20 cGy. In the final analyses the 400 cGy data were excluded 
because the frequencies of micronuclei and bridges were often lower than in cells 
exposed to 300 cGy. Inclusion of the 400 cGy data would have decreased the slopes of 
the high-dose responses leading to artificial increases in the ratios of low- to high-dose 
slopes, which would have exaggerated the apparent HRS effects. The frequencies of 
MN and bridges seen at 400 cGy likely underestimate the actual cytogenetic damage 
for two reasons. First, multiple acentric fragments can be packaged into one 
micronucleus, and multiple dicentrics may contribute to one bridge. Second, heavily 
damaged cells would be less likely to survive long enough to be evaluated.  
 
Nuclear division indices (NDI) 
 NDI were individually calculated for cells irradiated in G1 and G2 at 0 – 400 cGy 
for all four cell lines (Table 2.1). The average NDI values were 1.12 for G2 irradiated 
cells and 1.32 for G1 irradiated cells (data taken from Table 2.1). There were adequate 
numbers of scorable binucleated cells to enumerate MN and bridges throughout all the 
experimental conditions used in this study. There is no evidence of any dose-related 
response threshold from the analyses of the NDI values. 
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Table 2.1. Nuclear division index data by cell line, cell cycle phase, and dose. 
Dose 
(cGy) Nuclear Division Index 
  GM15510  GM15036  GM15526  GM15568 
  G2 G1  G2 G1  G2 G1  G2 G1 
0  1.12 1.32  1.17 1.34  1.13 1.46  1.10 1.43 
5  1.10 1.33  1.12 1.36  1.12 1.47  1.10 1.46 
10  1.10 1.53  1.18 1.38  1.08 1.53  1.10 1.51 
20  1.09 1.35  1.18 1.23  1.11 1.49  1.11 1.50 
40  1.14 1.50  1.11 1.25  1.08 1.47  1.07 1.35 
60  1.16 1.47  1.18 1.37  1.09 1.48  1.10 1.32 
80  1.07 1.30  1.17 1.30  1.11 1.39  1.10 1.34 
100  1.26 1.33  1.14 1.23  1.06 1.36  1.10 1.26 
200  1.15 1.19  1.18 1.18  1.10 1.30  1.11 1.16 
300  1.15 1.11  1.18 1.17  1.04 1.13  1.11 1.09 
400  1.22 1.12  1.17 1.10  1.10 1.12  1.06 1.07 
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Low-dose G2 slopes compared to low-dose G1 slopes  
 The ratios of the low dose (0 – 20 cGy) response slopes of the cells irradiated in 
G2 and G1 were compared for MN (Figures 2.2, 2.3) and bridges (Figures 2.4, 2.5). 
Univariate regression analyses were performed individually for each cell line and 
replicate. As shown in Table 2.2, the slopes of the low-dose responses in G2 were at 
least 3.1-fold steeper for MN and 2.4-fold steeper for bridges (p < 0.02 in each case), 
than the slopes observed in G1. These results indicate that the HRS effect is clearly 
evident in G2 and not in G1 irradiated cells for both endpoints. Multivariate regression 
analyses on all cell lines considered together indicate that the slope for low doses in G2 
is 6.9-fold steeper for MN (p < 0.0001) and 9.3-fold steeper for bridges (p < 0.0001) 
compared to the corresponding dose region in G1 (Table 2.2). Thus for all four cell lines 
considered together, the low-dose HRS effect is seen in G2 and not in G1. 
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Figure 2.2. MN frequencies in Cobalt-60 gamma-irradiated G2 cells by dose 
for four human lymphoblastoid cell lines. Univariate regression analyses were 
performed to obtain the slopes for the low (≤ 20 cGy) and high (60 – 300 cGy) 
dose regions of the responses. Each panel depicts data for one cell line with 
replicate experiments (triangles: replicate 1; squares: replicate 2).  
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Figure 2.3. MN frequencies in Cobalt-60 gamma-irradiated G1 cells by dose 
for four human lymphoblastoid cell lines. Univariate regression analyses were 
performed to obtain the slopes for the low (≤ 20 cGy) and high (60 – 300 cGy) 
dose regions of the responses. Each panel depicts data for one cell line with 
replicate experiments (triangles: replicate 1; squares: replicate 2). 
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Figure 2.4. Bridge frequencies in Cobalt-60 gamma-irradiated G2 cells by dose 
for four human lymphoblastoid cell lines. Univariate regression analyses were 
performed to obtain the slopes for the low (≤ 20 cGy) and high (60 – 300 cGy) 
dose regions of the responses. Each panel depicts data for one cell line with 
replicate experiments (triangles: replicate 1; squares: replicate 2). 
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Figure 2.5. Bridge frequencies in Cobalt-60 gamma-irradiated G1 cells by dose 
for four human lymphoblastoid cell lines. Univariate regression analyses were 
performed to obtain the slopes for the low (≤ 20 cGy) and high (60 – 300 cGy) 
dose regions of the responses. Each panel depicts data for one cell line with 
replicate experiments (triangles: replicate 1; squares: replicate 2). 
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Table 2.2. Comparisons of G2 and G1 slopes in the low dose region. 
Cell line Replicate  G2  G1  Ratio of 
slopes 
 p-value 
   Slope S.E.  Slope S.E.     
Micronuclei            
All cell lines 1 & 2  3.97 0.37  0.57 0.14  6.93  < 0.0001 
GM15510 1  4.51 1.29  0.79 0.36  5.70  0.049 
 2  4.68 1.64  0.36 0.14  12.86  0.058 
 1 & 2  4.59 0.86  0.58 0.37  7.96  0.001 
GM15526 1  3.76 1.25  -0.06 0.25  -61.53  0.0401 
 2  4.25 1.72  0.32 0.22  13.13  0.086 
 1 & 2  4.01 0.88  0.13 0.19  30.51  0.0009 
GM15036 1  3.56 0.55  1.05 0.93  3.39  0.081 
 2  3.58 1.43  0.61 0.24  5.82  0.109 
 1 & 2  3.57 0.66  0.83 0.73  4.28  0.017 
GM15268 1  4.05 0.63  0.43 0.26  9.50  0.006 
 2  3.34 0.29  1.07 0.18  3.12  0.002 
 1 & 2  3.69 0.59  0.75 0.19  4.94  0.0004 
Bridges            
All cell lines 1 & 2  1.37 0.17  0.15 0.04  9.32  < 0.0001 
GM15510 1  0.91 0.28  0.16 0.10  5.62  0.06 
 2  1.11 0.36  0.11 0.09  10.24  0.073 
 1 & 2  1.01 0.21  0.13 0.13  7.47  0.004 
GM15526 1  1.58 0.39  0.45 0.06  3.53  0.045 
 2  1.33 0.18  0.22 0.04  6.00  0.0035 
 1 & 2  1.45 0.69  0.33 0.14  4.35  0.14 
GM15036 1  1.91 0.66  0.14 0.11  13.43  0.056 
 2  0.97 0.33  0.40 0.13  2.39  0.018 
 1 & 2  1.44 0.83  0.27 0.10  5.28  0.19 
GM15268 1  2.06 0.87  0.05 0.07  41.31  0.083 
 2  1.09 0.36  0.15 0.02  7.03  0.056 
 1 & 2  1.57 1.07  0.10 0.15  15.40  0.19 
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G2 slopes, low- versus high- dose regions  
 Figures 2.2 and 2.4 indicate that the slopes of the frequencies of MN and 
bridges, respectively, induced in G2 were much higher at low doses (0 – 20 cGy) than 
high doses (60 - 300 cGy). To evaluate these differences further, the ratios of the slopes 
of the low- and high-dose regions were calculated. Univariate linear regression analyses 
(Table 2.3) showed that the slopes at low doses were at least 7-fold steeper for MN and 
10-fold steeper for bridges compared to the slopes at high doses when both replicates 
in all four cell lines were evaluated independently (p < 0.025 in each case). Similarly, 
multivariate linear regression analyses showed that the slope of the response in the low 
dose region is at least 13-fold and 19-fold steeper for MN and bridges, respectively (p < 
0.0001 in each case) than at high doses (Table 2.3). Taken together, the univariate and 
multivariate analyses clearly indicate that the HRS effect is observed at low doses in G2 
cells for both endpoints, and that the responses in G2 cells, over a broad range of 
doses, is not linear, i.e. the dose response for cells irradiated does not follow a LNT 
model. 
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Table 2.3. Comparisons of G2 slopes in the low dose and the high dose regions. 
Cell line Replicate  Low dose  High dose  Ratio of 
slopes 
p-value 
   Slope S.E.  Slope S.E.     
Micronuclei            
All cell lines 1 & 2  3.97 0.37  0.29 0.02  13.53  < 0.0001 
GM15510 1  4.51 1.29  0.14 0.07  32.45  0.009 
 2  4.68 1.64  0.38 0.04  12.45  0.011 
 1 & 2  4.59 0.86  0.26 0.08  17.85  0.0006 
GM15526 1  3.76 1.25  0.29 0.10  12.77  0.048 
 2  4.25 1.72  0.28 0.06  15.03  0.025 
 1 & 2  4.01 0.88  0.29 0.08  13.88  0.002 
GM15036 1  3.56 0.55  0.43 0.06  8.25  0.006 
 2  3.58 1.43  0.31 0.03  11.37  0.020 
 1 & 2  3.57 0.66  0.37 0.07  9.56  0.0009 
GM15268 1  4.05 0.63  0.56 0.07  7.28  0.021 
 2  3.34 0.29  0.43 0.08  7.75  0.009 
 1 & 2  3.69 0.59  0.49 0.06  7.48  0.0005 
Bridges            
All cell lines 1 & 2  1.37 0.17  0.07 0.01  19.16  < 0.0001 
GM15510 1  0.91 0.28  0.09 0.02  10.25  0.025 
 2  1.11 0.36  0.12 0.03  9.24  0.043 
 1 & 2  1.01 0.21  0.10 0.02  9.67  0.0007 
GM15526 1  1.58 0.39  0.02 0.04  72.42  0.024 
 2  1.33 0.18  0.02 0.02  84.17  0.003 
 1 & 2  1.45 0.69  0.02 0.06  77.35  0.060 
GM15036 1  1.91 0.66  0.06 0.02  32.93  0.009 
 2  0.97 0.33  0.07 0.02  14.27  0.025 
 1 & 2  1.44 0.83  0.06 0.05  22.89  0.089 
GM15268 1  2.06 0.87  0.12 0.02  16.51  0.025 
 2  1.09 0.36  0.05 0.03  19.94  0.034 
 1 & 2  1.57 1.07  0.09 0.05  17.55  0.11 
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G1 slopes, low- versus high-dose regions 
 The slopes of the G1 responses at low and high doses for MN (Figure 2.3) and 
bridges (Figure 2.5) were then compared for all four cell lines. Univariate regression 
analyses revealed that the ratios of the low- to high-dose responses for both replicates 
in all four cell lines averaged about 1.2 for MN and 1.1 for bridges (data taken from 
Table 2.4). Multivariate regression analyses revealed that the ratios of the low- to high-
dose slopes averaged 1.1 for MN and 1.03 for bridges; neither ratio is statistically 
different from 1.0 (Table 2.4). These univariate and multivariate results show that for all 
four cell lines, irradiation in G1 produces little or no HRS effect for either endpoint, thus 
LNT models for assessing radiation damage in G1 would appear to be appropriate.  
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Table 2.4. Comparisons of G1 slopes in the low dose and high dose regions.  
Cell line Replicate  Low dose  High dose  Ratio of 
slopes 
p-value 
   Slope S.E.  Slope S.E.     
Micronuclei            
All cell lines 1 & 2  0.57 0.14  0.50 0.03  1.14  0.62 
GM15510 1  0.79 0.36  0.64 0.04  1.23  0.78 
 2  0.36 0.14  0.47 0.07  0.78  0.54 
 1 & 2  0.58 0.37  0.55 0.05  1.04  0.97 
GM15526 1  -0.06 0.25  0.42 0.05  -0.15  0.42 
 2  0.32 0.22  0.59 0.04  0.55  0.58 
 1 & 2  0.13 0.19  0.51 0.06  0.26  0.54 
GM15036 1  1.05 0.93  0.42 0.15  2.51  0.73 
 2  0.61 0.24  0.46 0.08  1.34  0.86 
 1 & 2  0.83 0.73  0.44 0.08  1.90  0.68 
GM15268 1  0.43 0.26  0.56 0.07  0.77  0.87 
 2  1.07 0.18  0.45 0.07  2.39  0.48 
 1 & 2  0.75 0.19  0.49 0.06  1.51  0.68 
Bridges            
All cell lines 1 & 2  0.15 0.04  0.14 0.01  1.03  0.75 
GM15510 1  0.16 0.10  0.15 0.03  1.07  0.89 
 2  0.11 0.09  0.10 0.02  1.09  0.97 
 1 & 2  0.13 0.13  0.13 0.03  1.08  0.97 
GM15526 1  0.45 0.06  0.20 0.03  2.29  0.014 
 2  0.22 0.04  0.17 0.02  1.32  0.29 
 1 & 2  0.33 0.14  0.18 0.04  1.84  0.69 
GM15036 1  0.14 0.11  0.16 0.03  0.91  0.96 
 2  0.40 0.13  0.78 0.02  0.52  0.24 
 1 & 2  0.27 0.10  0.12 0.04  2.33  0.68 
GM15268 1  0.05 0.07  0.09 0.03  0.58  0.67 
 2  0.15 0.02  0.16 0.03  0.96  0.84 
 1 & 2  0.10 0.15  0.12 0.02  0.82  0.93 
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Radiation sensitivity per unit dose  
 Figures 2.6 and 2.8 show radiation sensitivity per unit dose in G2 for MN and 
bridges, respectively. Radiosensitivity is clearly much more evident at doses of 20 cGy 
and lower than at higher doses. However, as seen in Figures 2.7 and 2.9 for MN and 
bridges, respectively, G1 irradiated cells show little or no radiosensitivity, indicating that 
G2 cells are more radiation sensitive per unit dose than G1 cells for both endpoints. 
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Figure 2.6. Radiation sensitivities for MN in Cobalt-60 gamma-irradiated G2 
cells by dose for four human lymphoblastoid cell lines. The radiation 
sensitivities are the slopes of the line obtained between the frequency of MN at 
the 0 cGy dose and the frequency of MN at each individual higher dose. The 
G2 irradiated cells are more sensitive to radiation per unit dose for the low (≤ 
20 cGy) than the high (60 – 300 cGy) dose regions. Each panel depicts data 
for one cell line with replicate experiments (triangles: replicate 1; squares: 
replicate 2). 
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Figure 2.7. Radiation sensitivities of MN in Cobalt-60 gamma-irradiated G1 
cells by dose for four human lymphoblastoid cell lines. The radiation 
sensitivities are the slopes of the line obtained between the frequency of MN at 
the 0 cGy dose and the frequency of MN at each individual higher dose. The 
G1 irradiated cells show equal sensitivity to radiation per unit dose for the 
entire dose range (0 – 400 cGy). The negative values at some of the very low 
doses are due to low numbers of events. Each panel depicts data for one cell 
line with replicate experiments. The scale of the vertical axes are the same 
here and in Figure 2.6 (triangles: replicate 1; squares: replicate 2). 
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Figure 2.8. Radiation sensitivities of bridges in Cobalt-60 gamma-irradiated G2 
cells by dose for four human lymphoblastoid cell lines. The radiation 
sensitivities are the slopes of the line obtained between the frequency of 
bridges at the 0 cGy dose and the frequency of bridges at each individual 
higher dose. The G2 irradiated cells are more sensitive to radiation per unit 
dose for the low (≤ 20 cGy) than the high (60 – 300 cGy) dose regions of the 
responses. Each panel depicts data for one cell line with replicate experiments 
(triangles: replicate 1; squares: replicate 2). 
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Figure 2.9. Radiation sensitivities of bridges in Cobalt-60 gamma-irradiated G1 
cells by dose for four human lymphoblastoid cell lines. The radiation 
sensitivities are the slopes of the line obtained between the frequency of the 
bridges at the 0 cGy dose and the frequency of bridges at each individual 
higher dose. The G1 irradiated cells show equal sensitivity to radiation per unit 
dose for the entire dose range (0 – 400 cGy). The negative values at some of 
the very low doses are due to low numbers of events. Each panel depicts data 
for one cell line with replicate experiments. The scale of the vertical axes are 
the same here as in Figure 2.8 (triangles: replicate 1; squares: replicate 2). 
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DISCUSSION 
 HRS has been observed in many irradiated human cell lines using clonogenic 
cell assays (Krueger et al. 2010). HRS may be due to inefficient activation of ATM-
mediated DNA damage detection pathways at low doses that consequently fail to 
initiate a G2 arrest, allowing the radiation-damaged cells to enter mitosis (Wykes et al. 
2006). However, the mechanism of HRS is still not completely understood. Since 
ionizing radiation causes DNA strand breaks, we hypothesized that the increased cell 
death per unit dose observed following low dose exposures should be apparent with 
cytogenetic endpoints.  
 We observed HRS in all four cell lines for doses at 20 cGy and lower as indicated 
by multi-fold increases in the ratio of the low-dose slopes in G2 versus G1 irradiated 
cells. Visual inspection of the data indicated that the low dose responses for cell lines 
GM15510, GM15036 and GM15268 appeared steepest from 0 - 20 cGy, and that 
inclusion of the 40 cGy dose would have made the low-dose regression line less steep. 
However, in GM15526 cells inclusion of the 40 cGy dose would not have substantially 
changed the slopes for either endpoint (Figures 2.2 and 2.4). For the final analyses we 
took a consistent statistical approach and evaluated the responses from 0 - 20 cGy for 
all four cell lines. However, as shown in Figures 2.6 and 2.8, the steepest slopes were 
for responses from 0 – 5 cGy. Had we used only these data to determine the low-dose 
slopes, the ratio of low- to high-dose slopes would have been higher and 
correspondingly more statistically significant. Thus, the approach chosen here is 
conservative and these ratios of low- to high-dose slopes should be considered as 
minimum estimates.  
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 The observed differences in radiation sensitivities among the four cell lines may 
be due to genotypic differences among the people from whom these cell lines were 
originally established. These differences are consistent with data reported by various 
studies using clonogenic cell survival assays, where different cell lines exhibited an 
HRS effect for a range of doses ≤ 50 cGy (Marples et al. 2004; Dilworth et al. 2013; 
Schoenherr et al. 2013).  
 HRS is clearly seen in the G2 response for micronuclei and bridges. Comparison 
of the slopes at the low- and the high-dose regions of the dose-responses for both 
endpoints clearly indicate that G2 cells are more susceptible to damage per unit dose 
below 20 cGy than at higher doses (Figures 2.6 and 2.8). Several studies have shown 
that for doses below 30 cGy, cells do not appear to have efficient recognition of 
radiation-induced damage and thus are unable to activate the ATM-dependent G2/M 
checkpoint responsible for the repair, which leads to the HRS effect (Marples et al. 
2003; Krueger et al. 2007b; Krueger et al. 2010). Thus, the HRS observed in this study 
confirms the clonogenic cell survival results and supports the idea that the lack of 
activation of the G2/M check point may be at least partially responsible for the increased 
radiosensitivity. The biphasic nature of the cytogenetic responses in irradiated G2 cells 
cannot be attributed to changes in the NDI since these cells exhibited little or no 
disruption of normal cell progression based on the NDI data (Table 2.1). The 
association between HRS and cytogenetic damage is clearly indicated in our study, 
however to take complete advantage of this effect with radiotherapy or perhaps even 
with chemotherapy, the mechanism of activation of the G2/M checkpoint needs to be 
completely elucidated, possibly in cell lines that do not show any HRS effect. 
	  	  
46 
 The presence of HRS in G2-irradiated cells with bridges is a novel finding. 
Bridges in binucleated cells are associated with dicentrics, which are formed in G1. The 
presence of bridges in cells that were irradiated in G2 can be attributed to chromatid 
exchanges (“quadriradials”), many of which will be asymmetrical, i.e., one of the four 
chromatids will have two centromeres. These asymmetrical chromatid exchanges will 
lead to bridges in binucleated cells. 
 The G1 responses shown here did not exhibit an HRS effect for either endpoint, 
suggesting that most of the radiation-induced damage to G1 cells is repaired before the 
cells enter mitosis. The responses of the cells irradiated in G1 for the low and high 
doses were comparable as indicated by the ratio of slopes (Table 2.4) for both 
endpoints. These results indicate that the G1 responses follow a LNT model of radiation 
risk assessment.  
 This study demonstrates an HRS effect in G2-irradiated cells for micronuclei and 
nucleoplasmic bridges at doses up to 20 cGy in four normal human lymphoblastoid cell 
lines. The results indicate that back-extrapolation of the dose response curve from high 
to low doses may not always provide an accurate measure of the actual DNA damage 
or the most optimal risk assessments. The results also suggest that individuals may 
differ with respect to their radiosensitivities, which may complicate estimation of 
individual risks of low-dose effects. Our study indicates that HRS needs to be accounted 
for a thorough understanding of the risks involved with low dose exposures. 
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CHAPTER 3 
Effects of low oxygen levels on G2-specific cytogenetic low dose hyper-
radiosensitivity in irradiated human cells 
 
INTRODUCTION 
 Cells are traditionally cultured in vitro with ambient atmospheric conditions where 
oxygen (O2) levels are about 21%. In contrast, physiological O2 levels are approximately 
5% in normal tissue and may be lower in some solid tumor microenvironments. 
Compared to cells grown at physiological O2 levels, culturing cells in ambient O2 results 
in increased intracellular amounts of hydroxyl ions that result in DNA strand breaks 
(Henderson and Miller 1986; Boregowda et al. 2012; Koukourakis 2012). With hypoxic 
conditions the lower number of DNA strand breaks are repaired efficiently due to 
activation of ATM and ATR mediated DNA repair pathways (Cam et al. 2010; Mongiardi 
et al. 2011; Stagni et al. 2014). The biological effects of radiation are highly influenced 
by O2 levels, with hypoxia and anoxia making cells two to three times more resistant to 
radiation (Palcic et al. 1982; Marples et al. 1994b; Hockel and Vaupel 2001; Ma et al. 
2013). Tumor hypoxia, especially before radiotherapy, is known to be associated with 
poor clinical prognosis (Semenza 2012). Hypoxia is related to tumor development, 
metastatic capacity and malignant progression, and results in resistance to therapy at 
doses above 1 Gy (Brown et al. 2010; Hanahan and Weinberg 2011; Song et al. 2011).  
 Over the past few decades there has been tremendous progress in 
understanding the biological effects of radiation exposures ≤ 1 Gy. In vitro clonogenic 
cell survival assays have demonstrated increased death in cells irradiated below 30 cGy 
compared to exposures above 30 cGy, a phenomenon termed low dose hyper-
radiosensitivity (HRS) (Joiner et al. 2001a; Marples and Collis 2008). HRS is 
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predominantly seen in cells exposed to doses ≤ 30 cGy, especially when irradiation 
occurs in the G2 phase of the cell cycle (Wykes et al. 2006; Martin et al. 2013). The G2-
specific HRS is hypothesized to be due to inactivation of an ATM-dependent early G2/M 
checkpoint that causes inactivation of this DNA repair pathway, thus allowing damaged 
cells to enter mitosis (Xu et al. 2002; Krempler et al. 2007). We have previously 
observed HRS in G2-irradiated cells at exposures ≤ 20 cGy for four normal human 
lymphoblastoid cell lines, which were grown using standard in vitro cell culture 
techniques in ambient air (Joshi et al. 2014). 
 The validity of the HRS effect has been analyzed under numerous experimental 
conditions. The effects of dose rate (Marples and Collis 2008), priming dose (Joiner et 
al. 1996), O2 levels of cell cultures (Marples et al. 1994a) and cell cycle phase (Short et 
al. 2003) have all been evaluated, and HRS has also been shown to occur in vivo 
(Marples and Collis 2008; Martin et al. 2013). In contrast, HRS was not observed in 
Chinese hamster cells when they were exposed to hypoxia 1 hour before irradiation 
(Marples et al. 1994a; Marples et al. 1994b). However, a recent study showed that HRS 
was transiently diminished in human breast tumor T-47D cells that were cultured for 3 – 
6 weeks at 4% O2 levels and that upon re-oxygenation with 20% O2 the HRS effect was 
reestablished (Pettersen et al. 2007; Edin et al. 2012).  
 In the present study, we asked whether HRS occurs in cells cultured under low 
(2.5% and 5%) O2 levels compared to cells grown in ambient air. Cells in both G1 and 
G2 phases were exposed to Cobalt-60 gamma radiation at doses of 0 to 400 cGy and 
individually characterized for cytogenetic responses using the cytokinesis-blocked 
micronucleus assay. For G2-irradiated cells, HRS was not observed in cells cultured at 
	  	  
49 
2.5% or 5% O2, but was observed at ≤ 20 cGy in cells grown in ambient air. Because 
elimination of HRS was observed at low O2 levels, we also asked whether the loss of 
HRS was due to low O2 conditions before and / or after radiation exposure. We 
therefore characterized the radiation responses of the G2 cells under two conditions: a) 
re-oxygenation, in which the cells were irradiated in 5% O2 and then immediately 
transferred to ambient air, and b) hypo-oxygenation, in which the cells were irradiated in 
ambient air and then immediately transferred to 5% O2. We observed that re-
oxygenation resulted in an HRS effect at ≤ 20 cGy in both cell lines. A reverse effect 
was seen in hypo-oxygenated cells, wherein a pronounced reduction in HRS was 
observed for exposures ≤ 20 cGy. We did not observe HRS in G1-irradiated cells. 
However, we observed a reduction in the frequencies of MN and bridges in both G1 and 
G2 at 40 – 400 cGy. These results indicate that cells cultured in physiological O2 levels 
exhibit less gamma radiation-induced cytogenetic damage than cells cultured in ambient 
air, indicating that ambient O2 levels in tissue culture contribute to the HRS effects and 
exacerbate radiation sensitivities.  
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MATERIALS AND METHODS 
Cell lines and cell culture 
Two normal human lymphoblastoid cell lines, GM15510 and GM15036, were 
used in this study based on cytogenetic evidence for their HRS in our previous work 
(Joshi et al. 2014). Both cell lines were obtained from the Coriell Cell Repository and 
cultured using a protocol provided by Coriell either in ambient air (~21%) O2 or at low 
(2.5% or 5%) O2 levels. The cells were grown in T-10 flasks (Fisher Scientific, Pittsburg, 
PA) containing 5 ml of RPMI1640 medium (GIBCO, Grand Island, NY and Hyclone, 
Logan, UT) supplemented with 15% Fetal Bovine Serum (FBS, Atlanta Biologicals, 
Lawrenceville, GA), 2 mM L-glutamine (GIBCO, Grand Island, NY), penicillin-
streptomycin (100 units/ml penicillin G Sodium, 100 µg/ml streptomycin sulfate in 0.85% 
saline) (GIBCO, Grand Island, NY) and fungizone (amphotericin B, 2.5 µg/ml, 0.2 mm 
filtered) (Hyclone, Logan, UT). Under conditions of ambient air, the flasks had loosened 
caps. All cultures were maintained at 37°C and 5% CO2 in a fully humidified incubator, 
and passaged every three to four days when their density reached 106 cells/ml.  
 
O2 conditioned media (OCM) 
 Oxygen conditioned media was prepared by equilibration for at least 8 to 10 
hours in specialized Hypoxia Chambers (Billups-Rothenberg Inc., Del Mar, CA) in the 
presence of an artificial atmosphere with the desired O2 level (2.5% or 5%). The 
ambient air within these hypoxia chambers was replaced with a pre-mixed 
manufacturer-certified gas (Airgas, Wayne, MI) by continuous flushing at 25 liters per 
minute, measured using a Single Flow meter (Billups Rothenberg Inc., CA), for 4 
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minutes. The pre-mixed gas contained either 2.5% O2, 5% CO2 and 92.5% N2, or 5% 
O2, 5% CO2 and 90% N2. The percentage of O2 in the culture media was confirmed 
using a dissolved oxygen meter (YSI Inc., Yellow Springs, OH). 
 
Cell culture at low O2 levels  
  Prior to irradiation, the cells were seeded at 300,000 cells/ml and grown 
overnight in T10 flasks (Fisher Scientific, Pittsburg, PA) containing 5 ml of OCM. The 
culture flasks, with fully open caps, were maintained inside fully-sealed hypoxia 
chambers that were initially equilibrated as described above, then additionally gassed 
for 4 minutes, at 25 liters per minute, every 6-8 hours both before and after irradiation to 
maintain the O2 level. The inlet and outlet ports of the hypoxia chambers were tightly 
secured to prevent any gas exchange with the surrounding (ambient) air, and the 
chambers were then returned to the incubators and maintained at 37°.  
 
Irradiations 
 Ten to 12 hours after seeding the flasks in OCM, the flasks were retrieved from 
the hypoxia chambers and the caps were immediately tightened. To maintain the intra-
flask O2 environment, the flasks were immediately placed in plastic Ziploc bags that 
were then gassed for 4 minutes, at 25 liters per minute, with 2.5% or 5% O2 to flush out 
the ambient air. The Ziploc bags were then tightly sealed using labeling tape to maintain 
the O2 level. This procedure avoided the potential problem of a change in the intra-flask 
O2 levels that may result from the small amount of gas exchange that may occur 
through the plastic walls of the flasks. The Ziploc bags containing the flasks were then 
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transported in a thermal insulated container with pre-warmed packs to maintain the cells 
at 37°C. The cells were then acutely exposed to Cobalt-60 gamma radiation at a dose 
rate of approximately 27 cGy/min at the Gershenson Oncology Center, Wayne State 
University, Detroit, MI. Flasks from each cell line were exposed to 0, 5, 10, 20, 40, 60, 
80, 100, 200, 300, or 400 cGy. For re-oxygenation and hypo-oxygenation experiments 
the flasks were exposed to 0, 5, 10, 20, 40, 60, 80, or 100 cGy.  
 
Cell cycle kinetics and harvest 
We previously used flow cytometric analysis on both cell lines cultured at 
ambient O2 levels (Joshi et al. 2014) to measure cell cycle growth kinetics. These 
analyses revealed that for both cell lines, the G2 phase lasted approximately 1.5 - 2 
hours and that the G1 phase was approximately 20 - 22 hours in duration. The harvest 
times were based on these results to ensure that most binucleated cells scored were in 
G2 for the HRS effect (Joiner et al. 1993) or in G1.  
 Because O2 tension can influence cell cycle progression, the growth rates of 
these cells cultured at 2.5% and 5% O2 were determined by a cell viability assay using 
0.4% Trypan blue (in phosphate buffered saline; Fisher Scientific, Pittsburg, PA). Briefly, 
cells were seeded at an initial concentration of approximately 300,000 cells per ml and 
cultured at set O2 levels (2.5%, 5% and ambient air) in hypoxia chambers as described 
above. An aliquot of cells was taken every 24 hours. Trypan blue was added to this 
aliquot in a 1:1 ratio and the number of live cells per ml was determined using a 
standard hemocytometer (Fisher Scientific, Pittsburg, PA). The flasks were immediately 
returned to the hypoxia chambers and gassed for 2 minutes every 6 - 8 hours as 
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described above. The growth kinetics of both cell lines at 2.5 % and 5% O2 were 
comparable to those at ambient air, thus the harvest times were established as 2 and 
22 hours after radiation for the G2 and G1 phases, respectively.  
 
Re-oxygenation – cell culture 
 Both cell lines were cultured overnight in OCM maintained at 5% O2 levels in 
hypoxia chambers as described above. Prior to irradiation, the flasks were removed 
from the hypoxia chambers, the caps were immediately tightened and placed in Ziploc 
bags that were then flushed with premixed gas containing 5% O2, 5% CO2 and 90% N2 
to replace the ambient air and then irradiated as described above. Post-irradiation, the 
cells were transferred from the culture flasks into 15 ml Falcon centrifuge tubes then 
immediately pelleted by centrifugation at 1400 g for 5 minutes. Each cell pellet was 
immediately re-oxygenated by transferring it to 5 ml of pre-warmed media maintained at 
ambient O2 levels in T10 culture flasks which were then returned to the fully humidified 
incubators (i.e. not in hypoxia chambers) maintained at 37°C with 5% CO2 for 2 hours 
for G2, or 22 hours for G1, as described above.  
 Since re-oxygenation involved pelleting the cells by centrifugation, we included 
controls to rule out the possibility that this additional manipulation might influence the 
results. For these centrifuge controls, cells were cultured and irradiated at ambient air, 
then transferred to T-10 flasks containing pre-warmed media maintained at ambient air. 
The flasks were then returned to a fully humidified incubator and maintained at 37°C 
with 5% CO2 for 2 hours for G2, or 22 hours for G1, as described above.  
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Hypo-oxygenation – cell culture 
 Both cell lines were cultured and irradiated at ambient O2 levels at 37°C with 5% 
CO2 overnight as described above. Post irradiation, these cells were transferred from 
the culture flasks into 15 ml Falcon tubes then immediately pelleted at 1400 g for 5 
minutes. The cell pellets were immediately hypo-oxygenated by transferring them to 
T10 culture flasks containing 5 ml of pre-warmed OCM maintained at 5% O2 levels. The 
flasks were then placed in hypoxia chambers and gassed with 5% O2 as described 
above and immediately returned to the 37°C incubator for 2 hours for G2 and 22 hours 
for G1. Centrifuge controls were included in the experiment as described above for both 
cell lines. 
 
Cytokinesis-blocked micronucleus (CBMN) assay 
 Cytogenetic damage was measured using the CBMN assay (Fenech 2000; 
Cheong et al. 2013). Immediately post-irradiation, 6 µg/ml of Cytochalasin B (final 
concentration; Sigma Aldrich, St. Louis, MO) was added to each flask. All flasks were 
returned to the hypoxia chambers maintained at their set O2 levels, then returned to the 
incubator for 2 or 22 hours depending on the harvest time. The flasks were then 
removed from the hypoxia chambers and the caps were immediately tightened to avoid 
gas exchange with ambient air. The cells were resuspended and spun onto pre-cleaned 
microscope slides using a cytocentrifuge (Statspin, Westwood, MA) at 1300 g for 4 
minutes and then air-dried. The cells were fixed in 100% methanol (Fisher Scientific, 
Pittsburgh, PA) for 15 minutes and stained with 10% Giemsa (Sigma Aldrich, St. Louis, 
MO) dissolved in water for 15 minutes, then briefly rinsed in water and air-dried. 
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Data collection 
 Slide readers were extensively trained prior to data collection. Equivalent 
numbers of cells were scored by an equal number of readers for each treatment 
condition, for both cell lines and both harvest times. To ensure that adequate numbers 
of binucleated cells were available after irradiation for all O2 levels, the nuclear division 
index (NDI) was calculated as described (Eastmond and Tucker 1989a). Briefly, for 
each treatment condition a total number of 200 cells were counted to determine the 
frequency of cells with 1, 2, 3 or 4 nuclei using the formula 
 NDI = (M1 + 2M2 + 3M3 + 4M4) / N  
where M1 to M4 represent the number of cells with 1 to 4 nuclei and N is the total 
number of cells scored.  
 
Cell scoring criteria 
 Based on established criteria, the slides were evaluated for micronuclei, 
nucleoplasmic bridges, and buds simultaneously (Fenech 2000; Cheong et al. 2013) 
using Nikon Eclipse E200 light microscopes at 1000X magnification. Briefly, only 
binucleated cells with intact cell membranes were scored where the two main nuclei 
were separate from each other. Micronuclei were required to be one-third the size of the 
main nuclei or smaller. Each micronucleus had to be located within the cytoplasm, 
stained similar to the main nuclei with smooth edges, and shaped round or oval. 
Nucleoplasmic bridges were required to be stained similar to and connected with both 
the main nuclei. Buds were also scored but they did not yield meaningful results and 
therefore, these data are not reported here. To avoid observer bias all slides were 
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coded prior to scoring. For each treatment condition, at least 1000 binucleated cells 
were scored.  
 
Statistical analyses 
The cytogenetic damage data were regressed against dose to characterize HRS 
effects by evaluating the slopes of the responses of the G1- and G2-irradiated cells. 
Multivariate analyses were performed separately for three different dose ranges: 0 – 20 
cGy, 40 – 100 cGy, and 200 – 400 cGy. Within each dose range the effects of O2 were 
evaluated based on a nominal categorization of the six O2 treatment levels, i.e. 2.5% 
O2, 5% O2, centrifuge controls, ambient air, post-exposure hypo-oxygenation, and post-
exposure re-oxygenation. The frequencies of MN and bridges per 1000 binucleated 
cells were regressed against terms for dose, cell line, O2 treatment group, and all the 
corresponding interaction terms. All analyses were performed separately for cells 
irradiated in G1 and G2. Tukey’s HSD test was used to make post-hoc comparisons. All 
analyses were performed using JMP software, version 6.0, SAS Institute Inc. The 95% 
confidence intervals were calculated as previously described (Lilienfeld et al. 1967).  
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RESULTS 
The effects of atmospheric O2 levels during cell culture on the frequencies of MN 
and nucleoplasmic bridges were assessed in cytokinesis-blocked binucleated normal 
human lymphoblastoid cells irradiated with Cobalt-60 gamma rays over a wide range of 
doses in G1 and G2 phases of the cell cycle. Table 3.1 shows the cytogenetic 
consequences of culturing and irradiating cells in 2.5% and 5% O2 compared to cells 
grown and irradiated in ambient air at low doses (0 - 20 cGy) (Figures 1 and 2). For MN 
the ratios of the response slopes of cells cultured and irradiated in ambient air at 0 - 20 
cGy were 9.6- and 7.3-fold higher at 2.5% and 5% O2, respectively for GM15510 cells, 
and 3.2- and 5.5-fold higher, respectively for GM15036 cells. These ratios indicate the 
presence of HRS when these cells are cultured in ambient air, and that HRS is lost at 
2.5% and 5% O2. For bridges, the low-dose slopes did not show consistent trends for 
either cell line at 2.5% or 5% O2. Since we observed low dose HRS at 5% O2, which 
approximates the physiological O2 concentration in most human tissues, we further 
studied the effects of re-oxygenating cells to ambient O2 levels immediately after 
irradiating them in 5% O2 (Figures 3 and 4). For both MN and bridges the dose 
responses for cells maintained entirely in ambient air and irradiated in G2 were very 
similar to the responses for cells that were cultured and irradiated in 5% O2 and then 
immediately re-oxygenated to ambient air levels at doses of 0 – 20 cGy (Table 3.1). 
These results indicate that the HRS response is restored when cells are cultured in 
ambient O2 levels post-irradiation. We also evaluated the consequences of hypo-
oxygenation, i.e. cells that had been  
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Table 3.1. Comparison of slopes at 0 – 20 cGy at different O2 levels for cells 
irradiated in G2. 
O2 levels Cell line  Slope S.E.  Slope S.E.  Ratio of 
slopes 
Micronuclei          
GM15510 Ambient air  4.51 1.29      
 Centrifuge     3.63 1.13  1.24 
 2.5%     0.47 0.07  9.62 
 5%     0.62 0.15  7.28 
 Re-oxygenation     3.71 0.43  1.22 
 Hypo-oxygenation     0.94 0.71  4.81 
GM15036 Ambient air  3.56 0.55      
 Centrifuge     3.95 1.27  0.90 
 2.5%     1.11 0.38  3.21 
 5%     0.65 0.33  5.49 
 Re-oxygenation     4.46 1.87  0.80 
 Hypo-oxygenation     0.19 0.67  18.33 
Bridges          
GM15510 Ambient air  0.91 0.28      
 Centrifuge     1.49 0.63  0.61 
 2.5%     0.18 0.24  5.08 
 5%     -0.15 0.39  -5.98 
 Re-oxygenation     1.23 0.32  0.74 
 Hypo-oxygenation     0.30 0.16  3.06 
GM15036 Ambient air  1.91 0.66      
 Centrifuge     1.42 0.68  1.35 
 2.5%     -0.71 0.39  -2.69 
 5%     0.18 0.51  10.91 
 Re-oxygenation     1.55 0.63  1.24 
 Hypo-oxygenation     0.26 0.18  7.28 
a: the ratio is obtained by comparing the slope at ambient air with other O2 slopes individually 
  
	  	  
59 
 
Figure 3.1. MN frequencies at different O2 levels in two human lymphoblastoid 
cell lines exposed to Cobalt-60 gamma rays in G2 or G1. In G2 cells irradiated 
in ambient air a clear local maximum is observed at 20 cGy for both cell lines, 
but no such effect is seen for cells irradiated in 2.5% or 5% O2. For G2-
irradiated GM15036 cells, MN frequencies are much reduced for 0 – 300 cGy 
in 2.5% and 5% O2. The responses of the G1 cells irradiated at 100 cGy and 
below are similar for all O2 levels, however at doses of 200 - 400 cGy the MN 
frequencies are considerably lower for both cell lines. The 0 – 100 cGy data 
appear in an expanded format in Fig. 3, along with additional data. 
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Figure 3.2. Frequencies of nucleoplasmic bridges at different O2 levels in two 
human lymphoblastoid cell lines exposed to Cobalt-60 gamma rays in G2 and 
G1. In G2 cells irradiated in ambient air a clear local maximum is observed at 20 
cGy for both cell lines, but no such effect is seen for cells irradiated in 2.5% or 
5% O2. Overall at doses of 0 – 300 cGy, the frequencies of bridges are much 
reduced in 2.5% and 5% O2 for both cell lines. The responses of the G1 cells 
irradiated at 20 cGy and below are similar for all O2 levels, however, at doses of 
40 – 100 cGy the frequencies of bridges appear to be similar. At 200 – 300 cGy 
the frequency of bridges is much reduced in 2.5% and 5% O2 in G1 for both cell 
lines. The 0 – 100 cGy data also appear in Fig. 4, along with additional data.  
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Figure 3.3. MN frequencies among normal human lymphoblastoid cells 
cultured in different O2 treatment levels and exposed to Cobalt-60 gamma rays 
in G2 or G1. In G2 cells cultured in ambient O2 following irradiation there is a 
clear local maximum response at 20 cGy. Cells cultured in atmospheres of 5% 
O2 or less following irradiation showed little to no such local maximum, 
indicating the absence of HRS at low O2 levels. At doses of 40 – 100 cGy, for 
G2-irradiated cells, the MN frequencies are lower at low O2 levels. The dose 
responses of the G1-irradiated cells are much more similar to each other than 
the G2-irradiated cells at all doses for all O2 treatment levels. The 2.5%, 5%, 
and ambient air data also shown in Fig. 1 at doses ≤ 100 cGy.  
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Figure 3.4. Frequencies of nucleoplasmic bridges among normal human 
lymphoblastoid cells cultured in different O2 treatment levels and exposed to 
Cobalt-60 gamma rays in G2 or G1. In G2 cells cultured in ambient O2 
following irradiation there is a clear local maximum response at 20 cGy. Cells 
cultured in atmospheres of 5% O2 or less following irradiation showed little to 
no such local maximum, indicating the absence of HRS at low O2 levels. At 
doses of 40 – 100 cGy, for G2-irradiated cells, the frequencies of bridges 
appear to be lower at low O2 levels post-irradiation. The dose responses of the 
G1-irradiated cells are much more similar to each other than the G2-irradiated 
cells at all doses for all O2 treatment levels. The 2.5%, 5%, and ambient air 
data are also shown in Fig. 2 for doses ≤ 100 cGy. 
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cultured and irradiated in ambient air and then were immediately transferred after 
irradiation to conditioned culture medium and an atmosphere of 5% O2 (Figures 3 and 
4). The ratios of the low dose slopes for cells irradiated in G2 in ambient air were at 
least 4.8- and 3-fold steeper for MN and bridges, respectively, compared to post-
irradiation hypo-oxygenated cells (Table 3.1), indicating that upon hypo-oxygenation the 
HRS effect is reduced compared to cells grown in ambient air.  
 We also studied the cytogenetic effects of low O2, post-irradiation re-oxygenation 
and hypo-oxygenation in the G1 phase. The average of the response slopes at 0 – 20 
cGy in both cell lines grown in 2.5% and 5% O2, and post-irradiation hypo-oxygenation, 
was approximately 1.9 for MN and 0.11 for bridges (data taken from Table 3.2). 
Furthermore, the response slopes of post-irradiation re-oxygenated cells were no 
greater than 1.63 for MN and 0.48 for bridges compared to cells maintained and 
irradiated in ambient air. None of the ratios of slopes for any of the O2 treatment levels 
compared to ambient air shown in Table 3.2 are statistically significant for either MN or 
bridges, indicating that the HRS effects were not seen in these cells in G1 at the O2 
levels used in this study. 
 Table 3.3 shows the low dose (0 – 20 cGy) response slopes of cells irradiated in 
G2 compared to the low dose response slopes for cells irradiated in G1 for each O2 
level and cell line for both MN and bridges. For MN, the slopes in G2 at ambient O2 
levels were at least 3.39-fold steeper than the G1 slopes, indicating a G2-specific HRS 
effect in ambient air. However at low O2 levels, the ratios of the slopes for both cell lines 
averaged 1.63 for MN (data taken from Table 3.3), indicating that G2-irradiated cells are 
more prone to cytogenetic  
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Table 3.2. Comparison of slopes at 0 -20 cGy at different O2 levels for cells 
irradiated in G1. 
O2 levels Cell line  Slope S.E.  Slope S.E.  Ratio of 
slopesa 
Micronuclei          
GM15510 Ambient air  0.79 0.36      
 Centrifuge     0.69 0.34  1.14 
 2.5%     0.80 0.09  0.98 
 5%     0.46 0.17  1.72 
 Re-oxygenation     2.01 0.33  0.39 
 Hypo-oxygenation     0.41 0.04  1.95 
GM15036 Ambient air  1.05 0.93      
 Centrifuge     1.14 0.22  0.93 
 2.5%     0.34 0.08  3.08 
 5%     0.48 0.29  2.19 
 Re-oxygenation     0.65 0.48  1.63 
 Hypo-oxygenation     0.53 0.22  2.00 
Bridges          
GM15510 Ambient air  0.16 0.10      
 Centrifuge     0.40 0.17  0.40 
 2.5%     0.24 0.02  0.67 
 5%     0.07 0.17  2.35 
 Re-oxygenation     0.34 0.15  0.48 
 Hypo-oxygenation     0.09 0.16  1.77 
GM15036 Ambient air  0.14 0.11      
 Centrifuge     0.19 0.32  0.74 
 2.5%     -0.03 0.16  -5.20 
 5%     0.07 0.31  2.10 
 Re-oxygenation     0.67 0.13  0.21 
 Hypo-oxygenation     -0.14 0.12  -1.04 
a: the ratio is obtained by comparing the slope at ambient air with other O2 slopes individually. 
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Table 3.3. Comparison of G1 and G2 slopes at different O2 levels.  
O2 levels Cell line  G2  G1  Ratio of 
slopes 
   Slope S.E.  Slope S.E.   
Micronuclei          
Ambient air GM15510  4.51 1.29  0.79 0.36  5.70 
 GM15036  3.56 0.55  1.05 0.93  3.39 
Centrifuge GM15510  3.63 1.13  0.69 0.34  5.25 
 GM15036  3.95 1.27  1.14 0.22  3.47 
2.5% GM15510  0.47 0.07  0.80 0.09  0.58 
 GM15036  1.11 0.38  0.34 0.08  3.25 
5% GM15510  0.62 0.15  0.46 0.17  1.35 
 GM15036  0.65 0.33  0.48 0.29  1.35 
Re-oxygenation GM15510  3.71 0.43  2.01 0.33  1.85 
 GM15036  4.46 1.87  0.65 0.48  6.89 
Hypo-oxygenation GM15510  0.94 0.71  0.41 0.04  2.31 
 GM15036  0.19 0.67  0.53 0.22  0.37 
Bridges          
Ambient air GM15510  0.91 0.28  0.16 0.10  5.62 
 GM15036  1.91 0.66  0.14 0.12  13.43 
Centrifuge GM15510  1.50 0.63  0.40 0.17  3.75 
 GM15036  1.55 0.63  0.19 0.32  8.04 
2.5% GM15510  0.18 0.24  0.02 0.17  9.28 
 GM15036  0.18 0.51  -0.03 0.16  -6.40 
5% GM15510  -0.15 0.39  0.07 0.17  -2.21 
 GM15036  -0.71 0.39  0.07 0.31  -10.47 
Re-oxygenation GM15510  1.23 0.32  0.34 0.15  3.66 
 GM15036  1.42 0.68  0.67 0.13  2.12 
Hypo-oxygenation GM15510  0.30 0.16  0.09 0.02  3.25 
 GM15036  0.26 0.18  -0.14 0.12  -1.92 
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damage at 2.5% and 5% O2 compared to the G1 irradiated cells. For bridges the 
average ratio of the slopes was negative, indicating there is no HRS effect for this 
endpoint at 2.5% or 5% O2. The average slope values for MN or bridges indicate that 
cells irradiated in G2 do not exhibit an HRS effect when grown in low levels of O2. 
Moreover, as indicated in Table 3.3, for cells irradiated in G2, re-oxygenation led to 
slopes that were at least 1.8-fold steeper for MN and 2.1-fold steeper for bridges than 
the slopes for cells irradiated in G1, indicating an HRS effect after increasing the post-
irradiation O2 to the ambient level. However, as indicated in Table 3.3, hypo-
oxygenation for cells irradiated in G2 did not consistently exhibit HRS for MN or bridges 
(Table 3.3).  
 Multivariate linear regression analyses were performed to evaluate the effects of 
O2 concentrations on the G2 and G1 responses for each of the three dose groups, i.e., 
0 – 20 cGy, 40 – 100 cGy, and 200 – 400 cGy (Tables 3.4, 3.5, and 3.6, respectively). 
For the dose groups 0 – 20 cGy and 40 – 100 cGy, a statistically significant O2 effect 
independent of the dose and cell line for both MN and bridges (p < 0.0001 in most 
cases) was observed in G2 and G1 (Tables 3.4 and 3.5). However for doses of 200 – 
400 cGy, a statistically significant O2 effect was observed both in G2 (p < 0.006) and G1 
(p < 0.0004) for MN, whereas for bridges, a significant O2 effect was only seen in G2 (p 
< 0.0001) and not in G1 (Table 3.6). None of the other factors were significant for either 
endpoint in the highest dose group. Overall, these results indicate that at low O2 levels 
the observed loss of HRS in G2-irradiated cells seen in Figures 1 and 2 is statistically 
significant. 
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Table 3.4. Multivariate analyses of 0 - 20 cGy dose responses in G2 and G1   
Source  df  G2  G1 
    Sum of 
squares 
F ratio p-value  Sum of 
squares 
F 
ratio 
p-value 
Micronuclei           
Dose  1   14,081.0  79.2 < 0.0001   1,590.5  51.7 < 0.0001 
Cell line  1   1,321.0  7.4 0.012   1,136.7  36.9 < 0.0001 
O2 level  5   33,542.8  37.7 < 0.0001   2,003.3  13.0 < 0.0001 
Dose * Cell 
line 
 1   0.05  0.0003 0.99   17.2  0.6 0.46 
Dose * O2 
level 
 5   7,208.0  8.1 < 0.0001   251.7  1.6 0.19 
Cell line * O2 
level 
 5   1,883.2  2.1 0.10   1,555.6  10.1 < 0.0001 
Dose * Cell line * 
O2 level 
5   275.6  0.3 0.90   238.9  1.6 0.21 
Bridges           
Dose  1   1,340.5  28.8 < 0.0001   72.1  10.3 0.004 
Cell line  1   879.3  18.9 0.0002   173.5  24.7 < 0.0001 
O2 level  5   7,261.9  31.2 < 0.0001   219.2  6.2 0.0008 
Dose * Cell 
line 
 1   7.6  0.2 0.69   0.5  0.1 0.79 
Dose * O2 
level 
 5   1,446.1  6.2 0.0008   90.1  2.6 0.054 
Cell line * O2 
level 
 5   391.0  1.7 0.18   90.6  2.6 0.053 
Dose * Cell line 
* O2 level 
5   141.1  0.6 0.70   22.4  0.6 0.67 
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Table 3.5. Multivariate analyses of 40 - 100 cGy dose response in G2 and G1  
Source  df  G2  G1 
    Sum of 
squares 
F 
ratio 
p-value  Sum of 
squares 
F ratio p-value 
Micronuclei           
Dose  1  12,251.5 324.3 < 0.0001  11,774.8 155.8 < 0.0001 
Cell line  1  685.7 18.1 0.0003  4.6 0.1 0.0808 
O2 level  5  32,678.2 173.0 < 0.0001  12,050.9 31.9 < 0.0001 
Dose * Cell 
line 
 1  3.2 0.1 0.77  113.8 1.5 0.23 
Dose * O2 level 5  1,859.0 9.8 < 0.0001  1,133.1 3.0 0.03 
Cell line * O2 
level 
5  2,874.6 15.2 < 0.0001  2,335.5 6.2 0.0008 
Dose * Cell line * 
O2 level 
5  673.8 3.6 0.015  521.1 1.4 0.27 
Bridges           
Dose  1  231.8 11.6 0.0023  410.1 26.2 < 0.0001 
Cell line  1  502.2 25.1 < 0.0001  177.4 11.4 0.003 
O2 level  5  6,298.3 63.0 < 0.0001  1,232.6 15.8 < 0.0001 
Dose * Cell 
line 
 1  68.6 3.4 0.08  0.01 0.0004 0.98 
Dose * O2 level 5  69.2 0.7 0.63  277.2 3.5 0.02 
Cell line * O2 
level 
5  488.8 4.9 0.0032  334.5 4.3 0.01 
Dose * Cell line * 
O2 level 
5  379.0 3.79 0.011  163.8 2.1 0.10 
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Table 3.6. Multivariate analyses of 200 - 400 cGy dose responses in G2 and G1  
Source  df  G2  G1 
    Sum of 
squares 
F 
ratio 
p-value  Sum of 
squares 
F 
ratio 
p-value 
Micronuclei           
Dose  1  151.9 0.3 0.60  298.1 0.7 0.42 
Cell line  1  211.5 0.4 0.54  1,014.0 2.5 0.16 
O2 level  5  13,383.6 13.5 0.006  29,466.6 36.5 0.0004 
Dose * Cell line  1  1,380.0 2.8 0.15  215.8 0.5 0.49 
Dose * O2 level 5  1,520.5 1.5 0.29  1,027.8 1.3 0.35 
Cell line * O2 level 5  5,012.8 5.1 0.05  263.2 0.3 0.73 
Dose * Cell line * 
O2 level 
5  3,013.4 3.0 0.12  65.2 0.1 0.92 
Bridges           
Dose  1  58.0 3.1 0.13  260.4 1.7 0.24 
Cell line  1  17.6 1.0 0.37  285.8 1.8 0.23 
O2 level  5  3,324.1 89.6 0.0001  626.0 2.0 0.22 
Dose * Cell 
line 
 1  263.0 14.2 0.009  17.4 0.1 0.75 
Dose * O2 level 5  91.9 2.5 0.16  83.2 0.3 0.78 
Cell line * O2 
level 
5  90.2 2.4 0.17  1,082.7 3.5 0.10 
Dose * Cell line * 
O2 level 
5  17.6 0.47 0.64  722.3 2.3 0.18 
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Due to the high levels of statistical significance seen for O2 in the multivariate 
analyses, post-hoc tests were performed on the O2 treatment levels (Table 3.7). These 
analyses indicate which O2 levels differed from others in each of the three dose ranges, 
0 - 20 cGy, 40 – 100 cGy and 200 – 400 cGy. For MN, cells irradiated at all three dose 
ranges in G2 showed that responses in ambient air, the centrifuge control, and post-
irradiation re-oxygenation were all different from the responses at 2.5%, 5%, and post-
irradiation hypo-oxygenation. However, in G1 the O2 treatment groups partially 
overlapped in their responses at dose ranges 0 – 20 cGy and 40 – 100 cGy, but not at 
200 – 400 cGy. For bridges, the responses of cells irradiated in G2 in ambient air, the 
centrifuge control, and post-irradiation re-oxygenation were distinguishable from one 
another, but overall these responses clearly differed from those at 2.5%, 5%, and post-
irradiation hypo-oxygenation in all three dose ranges. In G1 the responses for bridges at 
all O2 levels showed more overlapping for the lower two dose ranges than was seen for 
MN, but at 200 – 400 cGy the O2 responses were statistically indistinguishable. 
Overall, these results clearly show lower frequencies of MN and bridges at low 
O2 levels in G1- and G2-irradiated cells in all three dose ranges compared to ambient 
air. G2-irradiated cells exhibited a loss of HRS at 0 - 20 cGy at low O2 compared to 
ambient air. Post-irradiation re-oxygenation of the G2-irradiated cells, led to 
reinstatement of the HRS effects at 0 - 20 cGy and an increase in cytogenetic damage 
for dose groups 40 – 100 and 200 – 300 cGy. In contrast, the post-irradiation hypo-
oxygenation results indicate loss of the G2-specific HRS effect at 0 - 20 cGy and an  
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a: Treatment group levels not connected by the same letter are significantly different from each other. 
b: Not all O2 levels were evaluated at high doses. 
 
O2 treatment 
condition
Least 
Squares 
Mean
Least 
Squares 
Mean
Least 
Squares 
Mean
Least 
Squares 
Mean
0 - 20 cGy 
Ambient air A 103.1 A 42.0 A 38.4 A 10.5
Centrifuge A 92.3 B C 32.7 A 39.9 A 8.9
Re-oxygenation A 84.3 A B 34.1 B 23.6 A 7.9
2.5% B 52.2 D 22.1 B C 19.7 A B 7.1
5% B 40.5 B C D 28.6 C D 11.1 A B 6.8
Hypo-oxygenation B 34.9 C D 25.4 D 7.7 B 3.5
40 - 100 cGy 
Ambient air A 135.9 A 83.9 A 40.1 A 22.4
Centrifuge B 121.7 A B 72.8 A 39.3 A B 19.1
Re-oxygenation B 114.3 A 82.8 B 27.9 B 16.7
2.5% C 70.7 C 53.7 C 19.6 B 14.0
5% C 77.1 B C 60.1 C D 14.8 A B 13.8
Hypo-oxygenation C 72.7 D 39.8 D 10.4 C 6.1
200 - 400 cGyb
Ambient air A 184.4 A 202.1 A 54.4 A 44.7
2.5% B 135.3 B 109.5 B 31.5 A 34.0
5% B 120.6 B 125.2 C 22.0 A 31.0
Treatment 
group 
levelsa
Treatment 
group 
levelsa
Treatment 
group 
levelsa
Treatment 
group 
levelsa
Table 3.7. Post Hoc test results of the O2 treatment conditions for all dose groups for MN 
and Bridges in cells irradiated in G2 or G1.
Source
G2 G1 G2
Bridges
G1
Micronuclei
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overall reduction in cytogenetic damage for all three dose ranges. The G1-irradiated 
cells did not exhibit HRS at 0 – 20 cGy. Taken together these results indicate that 
cytogenetic damage is lower when cells are recovering from radiation exposure under 
conditions of low O2 than when cells are cultured in ambient O2. 
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DISCUSSION 
 Recently we observed HRS at doses ≤ 20 cGy in four normal human 
lymphoblastoid cell lines that had been irradiated with Cobalt-60 gamma rays (Joshi et 
al. 2014). HRS is a well-known G2-specific low-dose radiation response, however the 
mechanism of HRS is not very well understood, and prior to our previous work HRS had 
not been observed with a cytogenetic endpoint. In the present study we cultured and 
irradiated cells in either ambient air (21%) O2, 2.5% O2, or 5% O2. For cells irradiated in 
G2, a lack of HRS is evident at ≤ 20 cGy at low O2 levels compared to cells cultured and 
irradiated in ambient air (Figures 1 and 2). These results are highly statistically 
significant for MN and for bridges (Table 3.4; p < 0.0001). However, G1-irradiated cells 
did not show the low dose specific HRS response at any O2 level for either cell line. A 
previous study used a clonogenic cell survival assay and showed the loss of HRS at 4% 
O2 with T-47D (human breast carcinoma) cells (Edin et al. 2012). Here we studied the 
effects of equilibrating cells at 2.5% and 5% O2 before and immediately after irradiation, 
and then evaluated the cells for cytogenetic damage 2 hours (G2 phase) or 22 hours 
(G1 phase) later. This study provides the first cytogenetic evidence for the loss of HRS 
at low O2 levels in G2-irradiated normal human lymphoblastoid cells.  
 We further evaluated whether the lack of an HRS response in G2 cells was due 
to low O2 either prior or after irradiation. Since we observed a loss of HRS at 5% O2, 
which is the approximate physiological O2 concentration, we studied the effects of re-
oxygenation to ambient air immediately following exposure in cells that were irradiated 
at 5% O2. The results indicate that the HRS response is reinstated in G2-irradiated cells 
when re-oxygenation to ambient air begins immediately after exposure and continues 
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until the time of harvest. This return of HRS is similar to the response following G2-
irradiation for both cell lines when they were cultured, irradiated and maintained in 
ambient air throughout the entire experiment. These results indicate that reinstatement 
of HRS (Figures 3 and 4) is due to the return to ambient O2 concentration following 
irradiation at 5% O2 levels. Previous studies have demonstrated that re-oxygenation 
leads to increased intracellular reactive oxygen species (ROS) causing direct damage 
to DNA (Brown 1999; Overgaard 2007). Re-oxygenation of tumor cells is also known to 
alter the effectiveness of DNA repair processes through activation of a hypoxia inducible 
factor (Bristow and Hill 2008; Olcina et al. 2010; Pires et al. 2012). Based on these 
previous studies, the HRS response observed in our G2-irradiated cells upon post-
irradiation re-oxygenation may be due, at least in part, to elevated levels of ROS. 
 To evaluate further the role of O2 after irradiation, we hypo-oxygenated cells to 
5% O2 that had been cultured and subsequently irradiated in ambient air. Hypo-
oxygenation resulted in a significantly diminished HRS effect in G2-irradiated cells for 
both cell lines (Figures 3 and 4). These findings suggest that reduced O2 levels post-
irradiation result either in reduced DNA damage due to diminished ROS, or that the 
ATM-mediated DNA damage repair pathway is activated. Activation of the ATM 
pathway is mediated through a complex containing MRE11, RAD50, and NBS1 (MRN 
complex) (Bencokova et al. 2009; Thompson 2012) 
 Multivariate regression analyses of the data presented here indicate that for MN 
and bridges, low O2 levels post-irradiation lead to the loss of HRS in G2 cells irradiated 
at 0 - 20 cGy (Table 3.4). Regression analyses also revealed an overall reduction in the 
frequencies of both MN and bridges in G1-irradiated cells (Table 3.4) at doses 0 -20 
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cGy. Overall, for both MN and bridges, O2 effects were also observed at dose groups 40 
– 100 cGy and 200 – 300 cGy in both G2 and G1 irradiated cells (Tables 3.5 and 3.6). 
The post-hoc tests indicate that for MN at all three dose ranges, the O2 treatment 
groups for G2-irradiated cells in ambient air, centrifuge control and post-irradiation re-
oxygenation are significantly different than when these cells are irradiated in 2.5%, 5% 
and post-irradiation hypo-oxygenation (Table 3.7). However, for MN the responses of 
the G1-irradiated cells overlap at all O2 levels and for all dose ranges. Taken together, 
the multivariate analyses and the post-hoc tests confirm that for MN the cytogenetic 
response of G2-irradiated cells is reduced in atmospheres of 2.5% and 5% O2, and in 
post-irradiation hypo-oxygenation compared to the responses of the same cells in 
ambient air, centrifuge control and post-irradiation re-oxygenation. For bridges at all 
three dose ranges, the responses of G2- and G1-irradiated cells in ambient air, 
centrifuge control and post-irradiation re-oxygenation are significantly different than 
when the cells are irradiated in atmospheres of 2.5% O2, 5% O2, and in post-irradiation 
hypo-oxygenation, however these responses overlap within each group (Table 3.7). 
 The results indicate that in both G2 and G1 phases of the cell cycle, a reduction 
in the frequencies of MN and bridges is observed when normal human lymphoblastoid 
cells are cultured and irradiated at 0 – 400 cGy in 2.5% or 5% O2. The G2-specific low 
dose HRS response in ambient air is lost when cells are irradiated at 0 - 20 cGy in 2.5% 
and 5% O2 while the HRS response is reinstated upon re-oxygenation to ambient O2 
levels. Cells irradiated in G1 did not exhibit HRS for any dose range at any O2 level 
tested here. Since many solid tumors are differentially oxygenated, our results suggest 
that tumor hypo-oxygenation may be of interest for enhancing the radiation therapy.  
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Chapter 2: 
 The dose-effect relationships of cells exposed to ionizing radiation are frequently 
described by linear quadratic (LQ) models over an extended dose range. However, 
many mammalian cell lines, when acutely irradiated in G2 at doses ≤ 0.3 Gy, show 
hyper-radiosensitivity (HRS) as measured by reduced clonogenic cell survival, thereby 
indicating greater cell lethality than is predicted by extrapolation from high-dose 
responses. We therefore hypothesized that the cytogenetic response in G2 cells to low 
doses would also be steeper than predicted by LQ extrapolation from high doses. We 
tested our hypothesis by exposing four normal human lymphoblastoid cell lines to 0 – 
400 cGy of Cobalt-60 gamma radiation. The cytokinesis block micronucleus assay was 
used to determine the frequencies of micronuclei and nucleoplasmic bridges. To 
characterize the dependence of the cytogenetic damage on dose, univariate and 
multivariate regression analyses were used to compare the responses in the low- (HRS) 
and high-dose response regions. Our data indicate that the slope of the response for all 
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four cell lines at ≤ 20 cGy during G2 is greater than predicted by an LQ extrapolation 
from the high-dose responses for both micronuclei and bridges. These results suggest 
that the biological consequences of low-dose exposures could be underestimated and 
may not provide accurate risk assessments following such exposures. 
 
Chapter 3: 
 Low-dose hyper-radiosensitivity (HRS) has been reported in normal human 
lymphoblastoid cell lines for exposures at ≤ 20 cGy, but the cytogenetic effects of 
oxygen (O2) levels in tissue culture media on HRS have not been evaluated. We asked 
whether HRS was lost in G2-irradiated cells grown in atmospheres of 2.5% or 5% O2, 
compared to responses by cells cultured in ambient (~21%) O2. The results indicate a 
loss of HRS when cells are cultured and irradiated either in 2.5% or 5% O2. We then 
evaluated whether low O2 levels either before or after exposure were responsible for the 
loss of HRS. For cells irradiated in an atmosphere of 5% O2, subsequent immediate re-
oxygenation to ambient O2 levels restored the HRS effect, while cells cultured and 
irradiated at ambient O2 levels and then transferred to 5% O2 exhibited little or no HRS, 
indicating that ambient O2 levels after, but not before, radiation substantially affect the 
amounts of cytogenetic damage. HRS was not observed when cells were irradiated in 
G1. At doses of 40 – 400 cGy there was significantly less cytogenetic damage when 
cells were recovering from radiation at low O2 levels than at ambient O2 levels. Here we 
provide the first cytogenetic evidence for the loss of HRS at low O2 levels in G2-
irradiated cells; these results suggest that at low O2 levels for all doses evaluated there 
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is either less damage to DNA, perhaps due to lower amounts of reactive oxygen 
species, or that DNA damage repair pathways are activated more efficiently.  
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